These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma. Wang DF; Lou N; Zeng CG; Zhang X; Chen FJ Ai Zheng; 2009 Feb; 28(2):154-8. PubMed ID: 19550128 [TBL] [Abstract][Full Text] [Related]
3. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma. Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation. Li SH; Lu HI; Chang AY; Huang WT; Lin WC; Lee CC; Tien WY; Lan YC; Tsai HT; Chen CH Oncotarget; 2016 Oct; 7(41):67150-67165. PubMed ID: 27564102 [TBL] [Abstract][Full Text] [Related]
5. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma. Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558 [TBL] [Abstract][Full Text] [Related]
6. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F. Yang H; Wei YN; Zhou J; Hao TT; Liu XL Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965 [TBL] [Abstract][Full Text] [Related]
7. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma. Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393 [TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma]. Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413 [No Abstract] [Full Text] [Related]
9. Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma. Nakahara Y; Yamasaki M; Sawada G; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mimori K; Mori M; Doki Y Oncology; 2016; 90(6):347-55. PubMed ID: 27082627 [TBL] [Abstract][Full Text] [Related]
10. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation. Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305 [TBL] [Abstract][Full Text] [Related]
11. Clinical and biological significance of stem-like CD133(+)CXCR4(+) cells in esophageal squamous cell carcinoma. Lu C; Xu F; Gu J; Yuan Y; Zhao G; Yu X; Ge D J Thorac Cardiovasc Surg; 2015 Aug; 150(2):386-95. PubMed ID: 26092504 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma. Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233 [TBL] [Abstract][Full Text] [Related]
13. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells. Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Li LY; Li EM; Wu ZY; Cao HH; Shen JH; Xu XE; Chen B; Wu JY; Xu LY Int J Clin Exp Pathol; 2014; 7(6):3132-40. PubMed ID: 25031732 [TBL] [Abstract][Full Text] [Related]
15. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma. Liu L; Yang Z; Ni W; Xuan Y Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036 [TBL] [Abstract][Full Text] [Related]
16. Integrin α5 promotes tumor progression and is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma. Xie JJ; Guo JC; Wu ZY; Xu XE; Wu JY; Chen B; Ran LQ; Liao LD; Li EM; Xu LY Hum Pathol; 2016 Feb; 48():69-75. PubMed ID: 26772401 [TBL] [Abstract][Full Text] [Related]
17. The expression of δ-catenin in esophageal squamous cell carcinoma and its correlations with prognosis of patients. Zhang JY; Bai CY; Bai YQ; Zhang JY; Wu ZY; Wang SH; Xu XE; Wu JY; Zhu Y; Rui Y; Li EM; Xu LY Hum Pathol; 2014 Oct; 45(10):2014-22. PubMed ID: 25090917 [TBL] [Abstract][Full Text] [Related]
18. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer. Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase D1 mRNA level may predict cancer-specific survival in heavy smokers with esophageal squamous cell cancers. Xie X; Zhang SS; Wen J; Yang H; Luo KJ; Yang F; Hu Y; Fu JH Dis Esophagus; 2014; 27(2):188-95. PubMed ID: 23621299 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma. Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]